The latest immunotherapy news and developments
‘Masked’ cancer drug sneaks through body to deliver anti-tumour treatment with fewer side effects
Many cancer treatments are notoriously savage on the body; they attack healthy cells at the…
Browsing: Immunotherapy
First patient injected with experimental cancer-killing virus in new clinical trial
Imugene Limited (ASX:IMU), a clinical-stage immuno-oncology company, and City of Hope, one of the largest…
ASCO 2022: Desmoplastic melanoma responds to PD-1 blockade immunotherapy
Tumours from desmoplastic melanoma, a rare cancer most commonly found on the head or neck,…
ASCO 2022: Next-generation immunotherapy drug shows continued promise in several advanced-stage cancers
Initial study results show that an experimental drug, called nemvaleukin alfa, when used alone or…
ASCO 2022: Immunotherapy drug combination is safe with promising results in glioblastoma
A novel combination of two experimental cancer immunotherapy agents along with an immune checkpoint blocker…
ASCO 2022: Novel immunotherapy combination improved survival in patients with metastatic melanoma
Combination immunotherapy treatment with anti-PD-1 and anti-CTLA-4 checkpoint inhibitors has proven effective as a front-line option for many patients…
Cancer immunotherapy capable of modulating tumour immunophenotypes
Innovations in cancer immunotherapy have achieved clinical success by considerably increasing the survival rate of…
Ultrasound-guided microbubbles boost immunotherapy efficacy
Researchers at The University of Texas MD Anderson Cancer Center, USA, have developed an ultrasound-guided…
Fluorescent probe can track cancer drug progress
The light-sensitive technology is able to detect which T cells are involved in attacking tumours.…
Electrochemical biosensor detects prostate cancer
Biomarkers are components that may be present in biological samples and are related to specific…